Correction: Polymorphisms at phase I-metabolizing enzyme and hormone receptor loci influence the response to anti-TNF therapy in rheumatoid arthritis patients (The Pharmacogenomics Journal, (2019), 19, 1, (83-96), 10.1038/s41397-018-0057-x)

ALEJANDRO ESCUDERO CONTRERASALEJANDRO ESCUDERO CONTRERASEDUARDO COLLANTES ESTÉVEZ2026-01-292026-01-29201910.1038/s41397-019-0084-22-s2.0-85061477711https://www.scopus.com/inward/record.uri?eid=2-s2.https://ucocris.uco.es/handle/123456789/30059GeneticsMolecular MedicinePharmacologyCorrection: Polymorphisms at phase I-metabolizing enzyme and hormone receptor loci influence the response to anti-TNF therapy in rheumatoid arthritis patients (The Pharmacogenomics Journal, (2019), 19, 1, (83-96), 10.1038/s41397-018-0057-x)corrigendum